Severe Combined Immunodeficiency (SCID Including Omenn Syndrome): DCLRE1C (Artemis) for RS‑SCID or SCIDA (Known Mutation)

Use

This test is intended to confirm a previously identified mutation in the DCLRE1C gene (Artemis) associated with recombination‑sensitive severe combined immunodeficiency (RS‑SCID) or SCIDA, including Omenn syndrome, in individuals with a documented family mutation.